|
|
|
|
| LEADER |
01430 am a22001813u 4500 |
| 001 |
134499 |
| 042 |
|
|
|a dc
|
| 100 |
1 |
0 |
|a Mitragotri, Samir
|e author
|
| 700 |
1 |
0 |
|a Burke, Paul A
|e author
|
| 700 |
1 |
0 |
|a Langer, Robert
|e author
|
| 245 |
0 |
0 |
|a Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies
|
| 260 |
|
|
|b Springer Science and Business Media LLC,
|c 2021-10-27T20:05:18Z.
|
| 856 |
|
|
|z Get fulltext
|u https://hdl.handle.net/1721.1/134499
|
| 520 |
|
|
|a © 2014 Macmillan Publishers Limited. All rights reserved. The formulation and delivery of biopharmaceutical drugs, such as monoclonal antibodies and recombinant proteins, poses substantial challenges owing to their large size and susceptibility to degradation. In this Review we highlight recent advances in formulation and delivery strategies - such as the use of microsphere-based controlled-release technologies, protein modification methods that make use of polyethylene glycol and other polymers, and genetic manipulation of biopharmaceutical drugs - and discuss their advantages and limitations. We also highlight current and emerging delivery routes that provide an alternative to injection, including transdermal, oral and pulmonary delivery routes. In addition, the potential of targeted and intracellular protein delivery is discussed.
|
| 546 |
|
|
|a en
|
| 655 |
7 |
|
|a Article
|
| 773 |
|
|
|t 10.1038/NRD4363
|
| 773 |
|
|
|t Nature Reviews Drug Discovery
|
